Drug Stocks March 2026: Top 3 Picks for Growth and Safety
In March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
As a new crypto investor, it's crucial to know what to watch out for to avoid costly mistakes. Equip yourself with knowledge to navigate the market safely.
27,825 articlesIn March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
U.S. prosecutors in New York investigate links between Colombia's president and drug traffickers, while the DEA desig...
Ondas (ONDS) reports its Q1 2026 results, revealing early signs of progress and persistent headwinds. This guide brea...
Small-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...
A respected investment firm recently disclosed a new stake in Portland General Electric, adding a signal to watch for...
As AI moves from training to deployment, the infrastructure behind inference could redefine winning investments. This...
As earnings season arrives, smart investors are drilling into Transcat's 2026 earnings outlook. This guide breaks dow...
Navitas Semiconductor carved out a standout session as investors reassessed growth catalysts in power semiconductors....
As AI expands, data-center construction flourishes. This piece explains why sterling infrastructure should regain mom...
A record-breaking bid for SpaceX could reshape the opening trading landscape. Here’s how inflows of demand influence ...
Investors are weighing a bold 2028 target for McDonald’s as loyalty growth and margin leverage could lift the stock, ...
Arm jumps on AI-driven data-center royalties, while Qualcomm climbs on automotive and data-center strength. The chip-...